(1S)-1-cyclohexyl-1-[4-[3-methyl-5-[[4-(trifluoromethyl)pyrimidin-2-yl]amino]phenyl]phenyl]ethanol
C26H28F3N3O — CID 130421829
Data last refreshed: (MolForge compound catalog, from PubChem)
About (1S)-1-cyclohexyl-1-[4-[3-methyl-5-[[4-(trifluoromethyl)pyrimidin-2-yl]amino]phenyl]phenyl]ethanol
(1S)-1-cyclohexyl-1-[4-[3-methyl-5-[[4-(trifluoromethyl)pyrimidin-2-yl]amino]phenyl]phenyl]ethanol (PubChem CID 130421829) has the molecular formula C26H28F3N3O and a molecular weight of 455.52 g/mol. Its IUPAC name is (1S)-1-cyclohexyl-1-[4-[3-methyl-5-[[4-(trifluoromethyl)pyrimidin-2-yl]amino]phenyl]phenyl]ethanol.
Molecular Properties
| Compound Name | (1S)-1-cyclohexyl-1-[4-[3-methyl-5-[[4-(trifluoromethyl)pyrimidin-2-yl]amino]phenyl]phenyl]ethanol |
|---|---|
| PubChem CID | 130421829 |
| Molecular Formula | C26H28F3N3O |
| Molecular Weight | 455.52 g/mol |
| Exact Mass | 455.22 |
| IUPAC Name | (1S)-1-cyclohexyl-1-[4-[3-methyl-5-[[4-(trifluoromethyl)pyrimidin-2-yl]amino]phenyl]phenyl]ethanol |
| SMILES | Cc1cc(Nc2nccc(C(F)(F)F)n2)cc(-c2ccc([C@@](C)(O)C3CCCCC3)cc2)c1 |
| InChI | InChI=1S/C26H28F3N3O/c1-17-14-19(16-22(15-17)31-24-30-13-12-23(32-24)26(27,28)29)18-8-10-21(11-9-18)25(2,33)20-6-4-3-5-7-20/h8-16,20,33H,3-7H2,1-2H3,(H,30,31,32)/t25-/m0/s1 |
| InChIKey | FYDQHPNQCUBJNW-VWLOTQADSA-N |
| XLogP | 7.00 |
| TPSA | 58.04 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 455.52 |
| LogP ≤ 5 | 7.00 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 130421829 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.